Biological and Clinical Efficacy of Shingrix in Patients With CLL

Clinical trial NCT06364033 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06364033
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma CLL-like MBL Varicella-zoster Virus Reactivation

Start date: 2024-08-01
Primary completion: 2025-11-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.